ESC 365 - Atomoxetine in patients with recurrent vasovagal syncope for preventing vasovagal attacks and improvement of depression and anxiety: a randomized double-blind placebo-controlled clinical trial

ESC Premium Access

Atomoxetine in patients with recurrent vasovagal syncope for preventing vasovagal attacks and improvement of depression and anxiety: a randomized double-blind placebo-controlled clinical trial

Session: Young Investigator Award Session Clinical Cardiology 2

Topic: Drug Treatment

Speaker: Assistant Professor M. Tajdini (Tehran, IR)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Assistant Professor Masih Tajdini

Tehran Heart Center, Tehran (Iran (Islamic Republic of))

0 follower

3 more presentations in this session

Visceral fat accumulation and left atrial phasic function in the general population

Speaker: Doctor N. Sawada (Tokyo, JP)

Application of the ESC and AHA guidelines for admission of syncope patients presenting to the ED

Speaker: Doctor J. Du Fay De Lavallaz (Basel, CH)

A nationwide 16-year study of the trends, burden and impact of atrial fibrillation in cardiac amyloidosis

Speaker: Doctor A. Isath (Valhalla, US)

Access the full session

Young Investigator Award Session Clinical Cardiology 2

Speakers: Assistant Professor M. Tajdini, Doctor N. Sawada, Doctor J. Du Fay De Lavallaz, Doctor A. Isath

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources